(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 27.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.04%.
Mediwound's earnings in 2025 is -$28,234,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2025 to be -$30,524,634, with the lowest MDWD earnings forecast at -$39,648,200, and the highest MDWD earnings forecast at -$23,067,213. On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$27,695,882, with the lowest MDWD earnings forecast at -$34,638,885, and the highest MDWD earnings forecast at -$20,783,331.
In 2027, MDWD is forecast to generate -$23,872,010 in earnings, with the lowest earnings forecast at -$30,801,962 and the highest earnings forecast at -$19,869,778.